| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Viemed Healthcare (NASDAQ:VMD) narrows FY2025 sales outlook from $271.000 million-$277.000 million to $271.000 million-$273.000...
Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.09 per share which met the analyst consensus estimate. This is...
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of t...
Viemed Healthcare (NASDAQ:VMD) raises FY2025 sales outlook from $256.000 million-$265.000 million to $271.000 million-$277.000 ...
Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.08 per share which met the analyst consensus estimate. This is...